723 related articles for article (PubMed ID: 30149763)
1. An overview of cancer immunotherapeutic strategies.
Wahid B; Ali A; Rafique S; Waqar M; Wasim M; Wahid K; Idrees M
Immunotherapy; 2018 Aug; 10(11):999-1010. PubMed ID: 30149763
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy as an Option for Cancer Treatment.
Rusch T; Bayry J; Werner J; Shevchenko I; Bazhin AV
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):89-96. PubMed ID: 29026920
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.
Steendam CM; Dammeijer F; Aerts JGJV; Cornelissen R
Immunotherapy; 2017 May; 9(6):507-520. PubMed ID: 28472903
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of cancers comes of age.
Yousefi H; Yuan J; Keshavarz-Fathi M; Murphy JF; Rezaei N
Expert Rev Clin Immunol; 2017 Oct; 13(10):1001-1015. PubMed ID: 28795649
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapies: Exploiting the Immune System for Cancer Treatment.
Koury J; Lucero M; Cato C; Chang L; Geiger J; Henry D; Hernandez J; Hung F; Kaur P; Teskey G; Tran A
J Immunol Res; 2018; 2018():9585614. PubMed ID: 29725606
[TBL] [Abstract][Full Text] [Related]
6. Cancer vaccines in the era of checkpoint blockade: the magic is in the adjuvant.
Overwijk WW
Curr Opin Immunol; 2017 Aug; 47():103-109. PubMed ID: 28806603
[TBL] [Abstract][Full Text] [Related]
7. NK cell-based immunotherapy for cancer.
Fang F; Xiao W; Tian Z
Semin Immunol; 2017 Jun; 31():37-54. PubMed ID: 28838796
[TBL] [Abstract][Full Text] [Related]
8. 'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.
Tran E; Robbins PF; Rosenberg SA
Nat Immunol; 2017 Feb; 18(3):255-262. PubMed ID: 28198830
[TBL] [Abstract][Full Text] [Related]
9. Update on the current revolution in cancer immunotherapy.
Renrick AN; Dunbar ZT; Shanker A
Immunotherapy; 2019 Jan; 11(1):15-20. PubMed ID: 30702010
[No Abstract] [Full Text] [Related]
10. Cancer treatment: The killer within.
Ledford H
Nature; 2014 Apr; 508(7494):24-6. PubMed ID: 24695297
[No Abstract] [Full Text] [Related]
11. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
[TBL] [Abstract][Full Text] [Related]
12. Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.
Khatami F; Torabi-Rahvar M; Kiani J; Naderi M; Ahmadbeigi N
Cytotherapy; 2018 Oct; 20(10):1227-1237. PubMed ID: 30266521
[TBL] [Abstract][Full Text] [Related]
13. Chimeric antigen receptor T cell therapy and other therapeutics for malignancies: Combination and opportunity.
Wang L; Yao R; Zhang L; Fan C; Ma L; Liu J
Int Immunopharmacol; 2019 May; 70():498-503. PubMed ID: 30875561
[TBL] [Abstract][Full Text] [Related]
14. The Role of Checkpoint Inhibitors and Cytokines in Adoptive Cell-Based Cancer Immunotherapy with Genetically Modified T Cells.
Gershovich PM; Karabelskii AV; Ulitin AB; Ivanov RA
Biochemistry (Mosc); 2019 Jul; 84(7):695-710. PubMed ID: 31509722
[TBL] [Abstract][Full Text] [Related]
15. Vaccines versus immunotherapy: overview of approaches in deciding between options.
Dalgleish AG
Hum Vaccin Immunother; 2014; 10(11):3369-74. PubMed ID: 25625932
[TBL] [Abstract][Full Text] [Related]
16. [Immunotherapy for cancer--modern immunologic strategies in oncology].
Halama N; Zoernig I; Jäger D
Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
[TBL] [Abstract][Full Text] [Related]
17. Current status and future prospects of peptide-based cancer vaccines.
Wada S; Yada E; Ohtake J; Fujimoto Y; Uchiyama H; Yoshida S; Sasada T
Immunotherapy; 2016 Nov; 8(11):1321-1333. PubMed ID: 27993087
[TBL] [Abstract][Full Text] [Related]
18. Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines.
Fecek RJ; Storkus WJ
Immunotherapy; 2016 Oct; 8(10):1205-18. PubMed ID: 27605069
[TBL] [Abstract][Full Text] [Related]
19. Novel approaches in cancer immunotherapy.
Subramaniam DS; Liu SV; Giaccone G
Discov Med; 2016 Apr; 21(116):267-74. PubMed ID: 27232512
[TBL] [Abstract][Full Text] [Related]
20. Cancer immunotherapy: the beginning of the end of cancer?
Farkona S; Diamandis EP; Blasutig IM
BMC Med; 2016 May; 14():73. PubMed ID: 27151159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
